Pharma Journalist -

Boston, MA (September 22, 2025) & Washington, D.C. (November 6, 2025). The LEAN Cell & Gene Summit series, co-organised by ScaleReady, and Hanson Wade, is proud to unveil its…
Read More...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Sanofi’s investigational gene therapy SAR402663 for treating neovascular age-related macular…
Read More...

Charles River Laboratories International, Inc. has announced two strategic partnerships aimed at advancing oncology research and accelerating the development of novel cancer therapies.…
Read More...

Zentiva, a leading European generics pharmaceutical company, has been sold by Advent International to GTCR, two major global private equity firms announced today. Advent acquired…
Read More...

The Chinese National Medical Products Administration (NMPA) has approved Tzield (teplizumab) as the country’s first disease-modifying therapy for autoimmune type 1 diabetes (T1D). The…
Read More...

Kriya Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering gene therapies for chronic diseases, has announced the closing of a $320 million Series D financing. The…
Read More...

Merck, known as MSD outside the U.S. and Canada, announced positive results from its Phase 3 STRIDE-13 trial evaluating CAPVAXIVE, its 21-valent pneumococcal conjugate vaccine, in…
Read More...

Kashiv BioSciences, LLC has announced a licensing and supply agreement with Brazilian pharmaceutical giant CRISTÁLIA for the commercialization of ADL-018, a proposed biosimilar to…
Read More...

Scipher Medicine, known for its AI-driven precision immunology platform, has announced a strategic collaboration with Maxymune Therapeutics, a biotech company focused on novel…
Read More...

Kytopen Corp., a leader in continuous flow cellular engineering, has announced a collaboration with BlueWhale Bio, a company focused on advancing cell-based therapies by revolutionizing…
Read More...